The Learning Curve of NBI With Magnification in the Diagnosis of Colorectal Lesions
NCT ID: NCT01431703
Last Updated: 2017-03-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
326 participants
OBSERVATIONAL
2010-05-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Diagnostic Accuracy for Predicting Histology of Colorectal Lesions
NCT01521091
The Value of Narrow Band Imaging in Stratifying Patients for Endoscopic Resection or Surgery
NCT01521104
Observation of Microvessels and Invasion in Early Colorectal Lesions by NBI
NCT02047188
Computer Aided Diagnosis of Colorectal Neoplasms During Colonoscopic Examination
NCT03069833
Diagnosis of Colonic Adenomas by Bright Narrow Band Imaging (B-NBI)
NCT01422577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any patient undergoing NBI with magnification colonoscopy exam and found with colorectal lesions
Exclusion Criteria
* Had surgery of colorectal tumors
* Using NSAIDS
* Diagnosed or suspected IBD
* Familial adenomatous polyposis(FAP) or hereditary non-polyposis colorectal(HNPCC) or other hereditary disease
16 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhizheng Ge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhizheng Ge
Shanghai Institute of Digestive Disease,Renji Hospital, Shanghai Jiao Tong University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
rjyyxhk0923
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.